other

Updated:

Envista Holdings Corporation

Envista Holdings unites 30+ dental brands post-spin from Danaher. Publicly traded two-segment platform with $2.6B in 2025 revenue.

Envista Holdings Corporation

Envista’s portfolio of implant, orthodontic, and dental digital workflow brands help dental professionals improve oral care.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Brea

Corporate office

Brea, CA, United States

Sector focus

DentalMedical Devices

Frequently asked questions

What is the relationship between Envista Holdings and Danaher?

Envista Holdings Corporation was spun off from Danaher Corporation in 2019. Danaher had built a portfolio of dental brands — including Nobel Biocare, Ormco, and Kerr — over multiple decades through acquisitions. The spin-off gave the dental business its own public listing on the NYSE and dedicated management structure, while the operating philosophy of continuous improvement carried over under the rebranded Envista Business System.

How does Envista Holdings generate revenue?

Envista operates through two commercial segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products division sells dental implant systems, prosthetics, clear aligners, bracket and wire orthodontics, and lab products. Equipment & Consumables sells digital imaging systems, practice equipment, endodontic supplies, restorative materials, bonding agents, and infection prevention products. The company reported $2.6 billion in total revenue for 2025 (per Envista Annual Report, 2025).

What brands does Envista Holdings own?

Envista's portfolio includes Nobel Biocare, a premium dental implant and prosthetics manufacturer; Ormco, a bracket and wire orthodontics company; Spark clear aligners; Kerr, which produces restorative materials, bonding agents, and cements; KaVo, a dental equipment brand; and DEXIS, a digital imaging brand. The company states it owns more than 30 dental brands, though a full list is not disclosed in a single public filing.

Is Envista Holdings a private equity-owned company?

No. Envista Holdings Corporation is a publicly traded company listed on the New York Stock Exchange under the ticker NVST. It does not operate as a private equity portfolio company, though its capital allocation strategy — acquiring founder-owned and corporate-carve-out dental businesses — shares tactical similarities with PE-backed consolidators.

Does Envista manufacture its own products?

Envista directly develops and manufactures a wide range of dental products, including dental implant systems, prosthetics, clear aligners, orthodontic brackets and wires, digital imaging systems, and restorative materials. Manufacturing responsibilities are distributed across the company's brand operating units rather than centralized in a single facility.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Brea other profiles